English | Español

Calithera Biosciences
+ Community
Carol Ostrow | Dec 26, 2017

Calithera presents results of breast cancer treatment study
+ Community
Ruth de Jauregui | Jun 17, 2017

Bristol-Myers Squibb, Calithera Biosciences to evaluate Opdivo, CB-839 in treating non-small cell lung cancer
+ Technology/Innovation
Robert Hadley | Jun 16, 2017

Calithera says trials indicate new drug can inhibit growth of solid tumors

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes